##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 107 Download : 84

##plugins.themes.academic_pro.article.main##

Abstract

Leiomyosarcoma (LMS) is a rare malignant tumor of smooth muscle origin that usually arises from soft tissues, reduced due to smooth muscle or vessel walls of venous origin. Renal leiomyosarcomas arise from the smooth muscle tissues of the renal pelvis, renal capsule, or renal vessels, and are most commonly encountered. This article presents clinical cases of diagnosis and surgical treatment of renal leiomyosarcoma found in the renal pelvis, complicated by extended thrombosis of the vena cava inferior (VCI).

Keywords

leiomyosarcoma of the kidney thrombosis vena cava inferior

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
G. G. Khakimova, V. S. Surkova, G. A. Khakimov, Zh.B. Sadullaev, & Sh. G. Khakimova. (2022). Leiomyosarcoma of the kidney with massive thrombosis of the inferior vena cava: a clinical case and a review of the literature. Texas Journal of Medical Science, 15, 9–16. https://doi.org/10.62480/tjms.2022.vol15.pp9-16
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Hui J.Y.C. Epidemiology and etiology of sarcomas. Surg Clin North Am 2016;96(5):901–14. DOI:10.1016/j.suc.2016.05.005.
  2. Guerrero M.A., Cross C.A., Lin P.H. et al. Inferior vena cava reconstruction using fresh inferior vena cava allograft following caval resection for leiomyosarcoma: midterm results. J Vasc Surg 2007;46(1):140–3.
  3. Laskin W.B., Fanburg-Smith J.C., Burke A.P. et al. Leiomyosarcoma of the inferior vena cava: clinicopathologic study of 40 cases.
  4. Am J Surg Pathol 2010;34(6):873–81.
  5. Tilkorn D., Hauser J., Ring A. et al. Leiomyosarcoma of intravascular – a rare tumor entity: clinical pathological study of twelve cases. World J Surg Oncol 2010;8:103–10.
  6. Niceta P, Lavengood RW, Jr, Fernandes M, Tozzo PJ.Leiomyosarcoma of kidney. Review of the literature. Urology 1974;3:270-7
  7. Lopez-Beltra A., Menendez C.L., Montironi R., Cheng L. Rare tumors and, tumor-like conditions
  8. in urological pathology. DOI: 10.1007/978-3-319-10253-5.
  9. Павлов А.Ю., Гармаш С.В., Исаев Т.К. и др. Современные пред- ставления о лейомиосаркомах вен забрюшинного пространства. Обзор клинических случаев. Онкоурология 2016;12(2):92–6. [Pavlov A.Yu.,
  10. Garmash S.V., Isaev T.K. et al. Current view: leiomyosarcoma of the veins
  11. of the retroperitoneum. Case histories review. Onkourologiya = Cancer Urology 2016;12(2):92–6. (In Russ.)].
  12. DOI: 10.17 650/1726-9776-2016-12-2-92-96.
  13. WHO classification of tumours of the urinary system and male genital organs. Eds.: H. Moch, P.A. Humphrey, T.M. Ulbright, V.E. Reuter. 4th edn.
  14. Дементьев И.О., Чайков В.С., Троянов А.В. и др. Редкая злокачественная опухоль почки – лейо- миосаркома почечной вены (клинический случай). Онкоурология 2022;18(1):143–50. DOI: 10.17650/1726-9776- 2022-18-1-143-150.
  15. Iwata J., Fletcher C.D. Immuno- histochemical detection of cytokeratin and epithelial membrane antigen in leiomyosarcoma: a systematic study
  16. of 100 cases. Pathol Int 2000;50(1):7–14. DOI: 10.1046/j.1440-1827.2000.01001.x.
  17. Deyrup A.T., Montgomery E., Fisher C. Leiomyosarcoma of the kidney: a clinico- pathologic study. Am J Surg Pathol 2004;28(2): 178–82. DOI: 10.1097/00000478- 200402000-00004.
  18. Р.А.Хвастунов, А.А. Юсифова Рак почки с массивным тромбозом нижней полой вены. Хирургическое лечение. Вестник ВолгГМУ 2017г., №2(62) DOI 10.19163/1994-9480-2017-2(62)-136-140
  19. Кригер А.Г., Берелавичус С.В., Сон А.И. и др. Хирургическое лечение неорганных забрюшинных опухолей. Хирургия. Журнал им. Н.И. Пирогова 2017;(1):15–26. [Kriger A.G., Berelavi- chus S.V., Son A.I. et al. Surgical treatment of retroperitoneal masses. Khirurgiya. Zurnal im. N.I. Pirogova = Pirogov Russian Journal of Surgery 2017;(1):15–26. (In Russ.)]. DOI: 10.17116/hirurgia2017115-26.
  20. Raut C.P., Pisters P.W. Review retroperitoneal sarcomas: combined-modality treatment approaches. J Surg Oncol 2006;94(1):81–7. DOI: 10.1002/jso.20543.
  21. Young S., Amirali S., Christopher S. et al. Renal leiomyosarcoma: case report and review of the literature. World J Nephrol Urol 2015;4(2):213–7. DOI: 10.14740/wjnu214w.
  22. Beardo P, José Ledo M, Jose Luis RC. Renal leiomyosarcoma. Rare Tumors. 2013 Sep 4;5(3):e42. doi: 10.4081/rt.2013.e42. PMID: 24179654; PMCID: PMC3804817.
  23. Bhat G., Nelivigi G., Shivalingaiah M. et al. Primary renal leiomyosarcoma:case report and literature review/ African Journal of Urology, 2011, Vol.17,№1:15-17
  24. Kwon Y.S., Salmasi A., Sejong C. et al. Renal leiomyosarcoma% case report and review of the literature/World Journal of nephrology and urology, 2015, Vol.4, №2:213-217
  25. Miettinen M, Fetsch JF.Evaluation of biological potential of smooth muscle tumours. Histopathology 2006;48:97-105
  26. Bevilacqua RG, Rogatko A, Hadju SI, Brennan MF.Pronostic factors in primary retroperitoneal soft-tissue sarcomas. Arc Surg 1991;126:328-34
  27. Raut CP, Pisters PW.Retroperitoneal sarcomas: combined-modality treatment aproaches. J Surg Oncol 2006;94:81-7
  28. Zafar R., Manthri S., Shurbaji M.S. Renal leiomyosarcoma. StatPearls Publishing, 2021.
  29. Mahmood T, Agresta S, Vigil CE, et al. Phase II study of sunitinib malate, a multi-targeted tyrosin kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma. Int J Cancer 2011;129:1963-9